Subject: | |
From: | |
Reply To: | |
Date: | Tue, 23 Oct 2007 08:02:24 -0600 |
Content-Type: | text/plain |
Parts/Attachments: |
|
|
Hi, Joe.
Here is one part of a conference report I did for my company upon
returning from this year's ARMA conference in Baltimore. I found this
particular session very informative.
Session: Creating a Global Retention Schedule for a Multinational
Company
Mark Weaver from the UK-based pharmaceutical company, AstraZeneca,
presented this session. It began with very basic information (what is a
retention schedule and why have one?) and I almost switched sessions but
am glad I stayed. He quickly got into the meat of his presentation by
using his company as the case study. Mark outlined how AZ put together
a truly global retention schedule - a 3Y process! He gave attendees
much food for thought: centralized v. decentralized records,
functional/process-based v. departmental, using the consultation phase
to market RIM and raise visibility, performing a variation analysis of
all current schedules, and admonishing us to document the entire
development process.
Key take-aways:
* A single schedule is the recommended final goal.
* Cross-reference all retention requirements to avoid duplication.
* Adopt highest level or standard.
* Declare and manage local variations.
* Be careful with time-based v. trigger/event-based disposition.
* Destruction deviations should be approved by RIM; document the
reason for deviation.
* Develop change control process for updates/changes to the
schedule.
* Create Global Governance Group for ongoing retention schedule
management.
You might want to look him up and contact him for more detailed info.
Hope this helps a bit.
Cheers,
Stephanie McCutcheon, CRM
Denver, Colorado
List archives at http://lists.ufl.edu/archives/recmgmt-l.html
Contact [log in to unmask] for assistance
To unsubscribe from this list, click the below link. If not already present, place UNSUBSCRIBE RECMGMT-L or UNSUB RECMGMT-L in the body of the message.
mailto:[log in to unmask]
|
|
|